VEGFA and retinopathy of prematurity: Among ROP in VLBWIs, 33.7% (231/686) underwent treatment: 63.6% (192) underwent conventional treatment only; 16.9% (84) underwent anti-VEGF treatment only; 19.5% (45) underwent both conventional and anti-VEGF treatment.